Sun Pharma buying Organon $11.75B, largest Indian pharma acquisition
NewsBytes | April 28, 2026 7:42 PM CST
Sun Pharma expects manageable debt
After the buyout, Sun Pharma expects its debt to stay manageable, thanks to strong cash flow and over $350 million in planned cost savings.
The company also plans to use Organon's worldwide network to push its specialty medicines further, aiming for bigger global reach and stronger earnings.
READ NEXT
-
Shreyas Iyer Issues Damning Statement After Punjab Kings' 1st Loss Of IPL 2026, Blaming These Players
-
Hyderabad man gets 25 years for raping neighbour’s 10-year-old son
-
Telangana CM orders fast-track of Tummidihetti Barrage, to seek Maharashtra nod
-
Top 10 tribal SSC scorers in Telangana all crossed 579 out of 600
-
NHRC registers case in Andhra Jyothi journalist’s murder
